Navigation Links
Dendreon Reports Second Quarter 2011 Financial Results
Date:8/3/2011

SEATTLE, Aug. 3, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today reported results for the second quarter ended June 30, 2011.  Net revenue for the quarter ended June 30, 2011 was $49.6 million compared to $2.8 million for the quarter ended June 30, 2010.  This included a $1.9 million reserve for estimated rebates and chargebacks associated with either Medicaid patients or other pricing discounts offered pursuant to mandatory federal and state government programs.  Gross revenue for the quarter ended June 30, 2011, excluding the impact of $1.9 million in estimated rebates and chargebacks, was $51.4 million compared to $2.8 million for the quarter ended June 30, 2010.  Net revenue for the six months ended June 30, 2011 was $77.6 million compared to $2.8 million for the six months ended June 30, 2010. Gross revenue for the six months ended June 30, 2011, excluding the impact of $2.3 million in estimated rebates and chargebacks, was $79.9 million.

Dendreon recorded a GAAP net loss for the quarter ended June 30, 2011 of $114.6 million, or $0.79 per share compared to a net loss of $142.6 million, or $1.04 per share for the quarter ended June 30, 2010.  GAAP net loss for the six months ended June 30, 2011 was $226.4 million, or $1.55 per share compared to $268.3 million, or $2.00 per share for the six months ended June 30, 2010.

On a pro-forma basis, excluding non-cash expenses associated with depreciation and amortization, non-cash imputed interest expense, and non-cash deferred stock compensation, Dendreon's net loss for the quarter ended June 30, 2011 was $83.5 million, or $0.57 per share, compared to $130.5 million, or $0.96 per share for the quarter ended June 30, 2010, which included a $0.55 charge for warrant revaluation.  The non GAAP net loss for the six months ended June 30, 20
'/>"/>

SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Dendreon Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate Cancer
2. Dendreon Announces Webcast Presentation at Newsmakers in the Biotech Industry Conference
3. Dendreon Announces Webcast Presentation at UBS Global Life Sciences Conference
4. Dendreon Presents Preclinical Data Validating Anti-Tumor Activity of D-3263, a Trp-p8 Agonist
5. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
6. Dendreon Reports Third Quarter 2008 Financial Results
7. Dendreon Announces Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
8. Dendreon Announces Webcast Presentation at Eleventh Annual BIO CEO & Investor Conference
9. Dendreon Reports Fourth Quarter and 2008 Year End Financial Results
10. Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer
11. Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Research and Markets  has announced ... (Biodegradable Polymer, Food & Beverage, Personal Care & ... report to their offering. Lactic ... asymmetrical carbon atom. The main applications of lactic ... beverage, personal care product, and pharmaceutical industries. ...
(Date:8/27/2014)... 27, 2014 Guggenheim Securities, the investment banking ... the hiring of veteran equity analyst Charles "Tony" Butler ... Butler will focus on the biotech/biopharma sector. ... of experience and a broad network of relationships in ... Director and Head of Equities at Guggenheim Securities. "His ...
(Date:8/27/2014)... Research and Markets  has announced the addition of ... Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... spectrometer industry. The report provides a basic ... industry chain structure. The isotope ratio mass spectrometer market ...
(Date:8/27/2014)... 2014 BIOEQUA, an innovative line of ... of a handheld spray, has made its EQUA ESSENTIAL ... , The brand began with an unexpected discovery in ... to learn that the application of nanospray technology allowed ... delivered directly to skin's basal layer. This resulted in ...
Breaking Biology Technology:Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2Global Stable Isotope Ratio Mass Spectrometer Industry Report 2014 2BIOEQUA'S EQUA ESSENTIAL Product Line Redefines Skin Care & Now Available in America 2
... - Automated Benchtop Workstation Aids Mass Spectrometer Analysis ... Life,Sciences, Inc. (Nasdaq: CALP ) today announced ... solution designed to automate Solid,Phase Extraction (SPE). With ... software interface, the Zephyr SPE Workstation is,designed to ...
... the, laparoscopic advanced energy market was worth over ... Dec. 11 Millennium Research Group,s US,Laparoscopic Marketrack(TM) ... advanced,energy market, which includes open and laparoscopic devices, ... demand for advanced energy instruments,from young physicians, these ...
... TB-402 Shows Clear Promise as a Stable Long-acting ... NV (Euronext Brussels:THR), a biotechnology company,focused on vascular ... the,first Phase I trial of TB-402 were presented ... 49th Annual Meeting in Atlanta,Georgia, USA. TB-402 is ...
Cached Biology Technology:Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction 2Young Physicians Demanding Advanced Laparoscopic Energy Instruments 2ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting 2ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting 3ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting 4
(Date:8/27/2014)... to listen carefully to someone, the first thing we ... is stop moving altogether. This strategy helps us hear ... movements. , This interplay between movement and hearing also ... evidence has long suggested that the brain,s motor cortex, ... gives rise to our conscious perception of sound. , ...
(Date:8/27/2014)... German . ... inherited disease affecting the peripheral nervous system. Researchers from ... of Experimental Medicine and University Medical Centre Gttingen have ... in rats with the disease. These cells enwrap the ... which facilitates the rapid transfer of electrical impulses. If ...
(Date:8/27/2014)... each year in U.S. waters and become what are ... crabs, and other species such as turtles. These traps ... who depend on the resources--losses that are largely preventable, ... report, published in the Marine Pollution Bulletin , ... derelict fish trap problem, and so-called "ghost fishing," nationally, ...
Breaking Biology News(10 mins):Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3Potential therapy for incurable Charcot-Marie-Tooth disease 2NOAA's Marine Debris Program reports on the national issue of derelict fishing traps 2
... been amazed by the power of gecko feet, which let ... carrying nine pounds up a wall without slipping. Now, a ... of Massachusetts Amherst have discovered exactly how the gecko does ... hold 700 pounds on a smooth wall. Doctoral candidate ...
... single most common cause of congestive heart failure and sudden ... of people throughout Central and South America. But as global ... States and Europe as well. Chagas, which is ... T. cruzi , is the leading cause of death among ...
... world,s top conferences in human-computer interaction, TEI 2012, is ... world are coming to Kingston to present the latest ... the technology on display includes: a two-sided flexible TV ... yoga mats; a glove for deaf-blind people that translates ...
Cached Biology News:Inspired by gecko feet, UMass Amherst scientists invent super-adhesive material 2UGA animal vaccine may slow deadly spread of Chagas disease 2UGA animal vaccine may slow deadly spread of Chagas disease 3
... fast and specific detection of chromosomal sequences ... hybridisation time ( Works ... Multiplex capability Available with different tags ... available with different labels. Related Content: ...
... rat adult and fetal tissue, ... * T75 plated cells $750.00, ... This product requires Celprogen Stem ... and extracellular matrix, * E55007-08-T25 ...
... Bacterial DNA Isolation Kit provides a rapid ... genomic DNA from the various bacterial species ... the isolation of genomic DNA from both ... milk samples. ,Purification is based on ...
...
Biology Products: